全部资讯｜CELL INTELLIGENCE

mRNA-based immunotherapy improves the efficacy of adoptively transferred TCR transgenic T cells in a murine solid tumour model.

PubMed 2026/08/08 发表Sci RepQ1 · IF 4.9（JCR 2025）

On the road to in vivo CAR-T success: Comparing promising viral and non-viral vectors.

PubMed 2026/04/26 发表Biotechnol AdvQ1 · IF 14.1（JCR 2025）

Engineering Immunity: Current Progress and Future Directions of CAR-T Cell Therapy.

PubMed 2026/01/16 发表Int J Mol SciQ1 · IF 5.6（JCR 2025）

mRNA-engineered T lymphocytes secreting bispecific T cell engagers with therapeutic potential in solid tumors.

PubMed 2025/11/18 发表Front ImmunolQ1 · IF 7（JCR 2025）

我们的结果强烈支持 mRNA 工程化的 TCE 分泌型 T 细胞作为一种有前景的实体瘤治疗策略。

Engineering mRNA CAR-T Cells for Cancer Immunotherapy.

PubMed 2025/01/01 发表Methods Mol Biol

An Innovative PTD-IVT-mRNA Delivery Platform for CAR Immunotherapy of ErbB(+) Solid Tumor Neoplastic Cells.

PubMed 2022/11/10 发表BiomedicinesQ2 · IF 4.5（JCR 2025）

A TCR-like CAR Promotes Sensitive Antigen Recognition and Controlled T-cell Expansion Upon mRNA Vaccination.

PubMed 2022/08/18 发表Cancer Res CommunQ2 · IF 4（JCR 2025）

全部资讯 7